1.425 USD
-0.09 (-6.25%)
ChartMill assigns a Buy % Consensus number of 82% to ALLO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.71. This target is 441.14% above the current price.
ALLO was analyzed by 20 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ALLO.
In the previous month the buy percentage consensus was at a similar level.
ALLO was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-08-04 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-08-04 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-05-15 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-14 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-14 | Citizens Capital Markets | Upgrade | Market Perform -> Market Outperform |
| 2025-03-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-08-09 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-31 | Piper Sandler | Initiate | Overweight |
| 2024-05-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-14 | Stifel | Maintains | Hold -> Hold |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-01-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-05 | Guggenheim | Downgrade | Buy -> Neutral |
ALLOGENE THERAPEUTICS INC / ALLO FAQ
Can you provide the average price target for ALLOGENE THERAPEUTICS INC stock?
20 analysts have analysed ALLO and the average price target is 7.71 USD. This implies a price increase of 441.14% is expected in the next year compared to the current price of 1.425.
Can you provide the consensus rating for ALLOGENE THERAPEUTICS INC stock?
The consensus rating for ALLOGENE THERAPEUTICS INC (ALLO) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ALLO stock?
The number of analysts covering ALLOGENE THERAPEUTICS INC (ALLO) is 20.